Ambrx Biopharma AMAM 深 沪
等待开盘 11-07 09:30:00 美东时间
28.00
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 28.00
- 总市值 173.63万
- 52周最高 28.15
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 6.55
- 委 比 0.00%
- 总股本 6.20万
- 历史最高 28.15
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.38
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Oncolytics Biotech® Announces Appointment of Steve Glover to Board of Directors and Promotion of John McAdory to Chief Operating Officer
Oncolytics Biotech announced the appointment of Steve Glover to its Board of Directors and the promotion of John McAdory to Chief Operating Officer. Glover brings extensive experience in public company leadership and transactions, including the sale of Ambrx Biopharma to Johnson & Johnson. McAdory, previously VP of Clinical Operations at CG Oncology, will oversee clinical operations, preclinical research, and strategic partnerships. Both addition...
06-02 13:00
143亿，强生收购一家ADC公司
“医谷” 近日，强生宣布已成功完成对抗体药物开发公司Ambrx Biopharma的收购。此次收购以全现金合并交易的形式完成，总股权价值约为20亿美元（约14...
2024-03-12 19:10
Ambrx Shareholders Approve Acquisition By Johnson & Johnson
As previously announced, under the terms of the transaction, Ambrx shareholders will receive $28.00 per share in cash in connection with the closing of the transaction.
2024-03-07 02:21
